This data, along with data linking Perlecan to metastatic tumor environments such a bone matrix [13], presents a general model in which Perlecan expression by tumor cells under poor growth conditions enhances their ability to utilize growth factors until their spread to suitable metastatic tumor microenvironments for accelerated growth. The gene discussed is HSPG2; the disease is neoplasm.